Roger C. L. Guillemin

Roger C. L. Guillemin's AcademicInfluence.com Rankings

Biology

#3018

World Rank

#4678

Historical Rank

Endocrinology

#10

World Rank

#12

Historical Rank

Neuroscience

#263

World Rank

#278

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Roger C. L. Guillemin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roger C. L. Guillemin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone (1973) (3343)
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. (1977) (1323)
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. (1982) (1226)
Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin (1986) (1072)
Basic fibroblast growth factor induces angiogenesis in vitro. (1986) (823)
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. (1976) (800)
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. (1986) (715)
Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β (1985) (705)
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. (1985) (647)
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. (1978) (618)
Foot-shock induced stress increases β-endorphin levels in blood but not brain (1977) (534)
Culture of Enzymatically Dispersed Anterior Pituitary Cells: Functional Validation of a Method (1972) (522)
β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND (1978) (482)
Peptides in the brain: the new endocrinology of the neuron. (1978) (446)
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. (1987) (431)
Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. (1985) (427)
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. (1977) (408)
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). (1972) (406)
Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. (1977) (406)
Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. (1986) (356)
Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. (1971) (354)
Characterization of Ovine Hypothalamic Hypophysiotropic TSH-releasing Factor (1970) (344)
Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. (1955) (338)
Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details. (1959) (332)
Effects of somatostatin on the secretion of thyrotropin and prolactin. (1974) (291)
Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. (1977) (287)
Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. (1984) (282)
Receptor- and heparin-binding domains of basic fibroblast growth factor. (1988) (282)
Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid. (1979) (278)
Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. (1977) (270)
Hypothalamic enkephalin neurones may regulate the neurohypophysis (1979) (247)
Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. (1985) (244)
Immunohistochemical detection of growth hormone-releasing factor in brain (1983) (242)
Primary structure of the human follistatin precursor and its genomic organization. (1988) (239)
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. (1974) (232)
Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. (1974) (228)
Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. (1986) (223)
Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. (1976) (214)
Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. (1982) (209)
Radioimmunoassays for a-endorphin and -endorphin (1977) (209)
Primary structure of bovine brain acidic fibroblast growth factor (FGF). (1985) (208)
Measurement of free corticosteroids in rat plasma: physiological validation of a method. (1958) (208)
Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). (1982) (201)
Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion (1981) (200)
Inhibition of growth hormone release in humans by somatostatin. (1973) (200)
Perinatal development of the endorphin- and enkephalin- containing systems in the rat brain (1979) (196)
beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. (1976) (188)
Isolation, primary structure, and synthesis of α-endorphin and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity (1976) (188)
Somatostatin: physiological and clinical significance. (1976) (186)
beta-Endorphin induces nonconvulsive limbic seizures. (1978) (181)
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. (1973) (174)
Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. (1978) (173)
Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. (1980) (172)
Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. (1987) (171)
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. (1982) (169)
A homodimer of the β-subunits of inhibin a stimulates the secretion of pituitary follicle stimulating hormone (1986) (168)
Inhibition of growth hormone secretion in the rat by synthetic somatostatin. (1974) (151)
Primary structure of PDC-109, a major protein constituent of bovine seminal plasma. (1983) (150)
Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. (1982) (148)
PROFOUND ANALGESIC EFFECTS OF β-ENDORPHIN IN MAN (1980) (146)
Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence (1984) (141)
Evidence for immunoreactive neurotensin in dog intestinal mucosa. (1976) (138)
Nychthemeral Variations in Plasma Free Corticosteroid Levels of the Rat.∗ (1959) (138)
Neural Modulation of Immunity (1984) (138)
Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin. (1977) (137)
A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. (1985) (134)
β-ENDORPHIN STIMULATES SECRETION OF ARGININE VASOPRESSIN IN VIVO (1977) (133)
Seven peptides derived from pro-somatostatin in rat brain. (1982) (133)
β-Endorphin: cellular localization, electrophysiological and behavioral effects (1979) (131)
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. (1983) (130)
Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men. (1983) (130)
Hypothalamic control of adenohypophysial secretions. (1973) (128)
Release of enkephalin from rat globus pallidus in vitro (1978) (128)
Gonadocrinins: Peptides in Ovarian Follicular Fluid Stimulating the Secretion of Pituitary Gonadotropins* (1981) (126)
TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. (1973) (123)
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. (1982) (122)
beta-Endorphin: endogenous opiate or neuroleptic? (1977) (122)
Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. (1982) (122)
Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin. (1975) (121)
Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. (1970) (120)
Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor (1972) (119)
Hypothalamic hormones a.k.a. hypothalamic releasing factors. (2005) (118)
Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation. (1980) (112)
Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary. (1978) (110)
High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25 (1981) (110)
Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. (1986) (108)
High-molecular-weight immunoreactive beta-endorphin in extracts of human placenta is a fragment of immunoglobulin G. (1980) (106)
A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. (1988) (103)
Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. (1982) (103)
Hypothalamic releasing factors. (1970) (103)
Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development. (1979) (101)
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. (1983) (101)
Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro. (1987) (100)
Isolation and partial characterization of basic fibroblast growth factor from bovine testis (1987) (99)
Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. (1983) (98)
Inhibition of Pancreatic Glucagon Responses to Arginine by Somatostatin in Normal Man and in Insulin-Dependent Diabetics (1974) (98)
Lack of effect on naloxone on schizophrenic symptoms. (1977) (97)
Synthesis and biological activity of four γ-melanotropin derived from the cryptic region of the adrenocorticotropin/β-lipotropin precursor (1979) (97)
Immunohistochemical detection of inhibin in the gonad. (1987) (94)
Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus. (1978) (88)
On the Presence in Hog Hypothalamus of (β-Corticotropin Releasing Factor, α- and (β-Melanocyte Stimulating Hormones, Adrenocorticotropin, Lysine-Vasopressin and Oxytocin (1962) (87)
Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo. (1979) (85)
[General adaptation syndrome]. (1952) (85)
Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related. (1987) (84)
Gonadotropin responses to synthetic LRF: dose-response relationship in men. (1973) (83)
Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. (1979) (83)
Control of corticotrophin release: further studies with in vitro methods. (1957) (82)
Immunoreactive calcitonin in the intermediate lobe of the pituitary gland. (1978) (82)
HYPOTHALAMIC FACTORS RELEASING PITUITARY HORMONES. (1964) (81)
Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. (1972) (81)
The adenohypophysis and its hypothalamic control. (1967) (80)
Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. (1984) (80)
Endorphins, brain peptides that act like opiates. (1977) (80)
Solid phase synthesis of somatostatin-28. (1980) (77)
[Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-NH2 sequence]. (1969) (74)
Characteristics of the pituitary binding sites for thyrotropin releasing factor. (1973) (73)
Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin. (1974) (69)
Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis. (1984) (69)
Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. (1982) (68)
Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt. (2009) (67)
S0MAT0STATIN-28tl-12)-LIKE IMMUNOREACTIVITY IN THE RAT (1982) (67)
Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs. (1976) (67)
IN VITRO SECRETION OF THYROTROPIN (TSH): STIMULATION BY A HYPOTHALAMIC PEPTIDE (TRF). (1963) (66)
Isolation of an amino terminal extended form of basic fibroblast growth factor. (1986) (64)
Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man. (1972) (63)
Isolation and characterization of rat pancreatic somatostatin. (1980) (63)
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: an effect of beta-MSH in the spinal cord of the cat. (1961) (62)
Somatocrinin, the growth hormone releasing factor. (1984) (61)
Inhibins and activins. (1988) (60)
Growth hormone releasing factors. (1985) (60)
Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25. (1980) (60)
Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. (1978) (58)
Presence of immunoassayable beta-endorphin in human amniotic fluid: elevation in cases of fetal distress. (1977) (58)
Foot-shock induced stress increases beta-endorphin levels in blood but not brain. (1977) (58)
Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus. (1973) (56)
On the Mechanism of Action of TRF: Effects of Cycloheximide and Actinomycin on the Release of TSH Stimulated in Vitro by TRF and its Inhibition by Thyroxine (1968) (55)
(DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats (1979) (55)
The hormones of the hypothalamus. (1972) (55)
Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway. (1980) (54)
Localization of γ-melanocyte stimulating hormone (γMSH) immunoreactivity in rat brain and pituitary (1980) (54)
Pituitary immunoreactive γ-melanotropins are glycosylated oligopeptides (1980) (53)
A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor. (1983) (52)
STUDIES ON THE CIRCADIAN RHYTHM OF PITUITARY ADRENOCORTICOTROPIC RELEASE IN MAN. (1963) (52)
β-Endorphin in obstetric analgesia☆ (1980) (52)
THE ENDORPHINS, NOVEL PEPTIDES OF BRAIN AND HYPOPHYSIAL ORIGIN, WITH OPIATE‐LIKE ACTIVITY: BIOCHEMICAL AND BIOLOGIC STUDIES (1977) (51)
Evidence for the Existence of Two Corticotrophin-releasing Factors, α and β (1960) (51)
ACTH Releasing Activity in vivo of a CRF Preparation and Lysine Vasopressin.∗ (1959) (50)
Somatostatin-28 [1-12]-like peptides. (1985) (50)
Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. (1970) (50)
ANGIOGENIC FACTOR IN HUMAN OCULAR FLUID (1985) (49)
Characteristics of β-endorphin-induced behavioral activation and immobilization (1979) (49)
Chromatography and hormonal activities of dog hypothalamus. (1962) (48)
A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. (1986) (46)
Growth Hormone-Releasing Factor: Chemistry and Physiology (1984) (45)
Chemistry of the hypothalamic releasing factors--studies on structure-function relationships. (1973) (45)
Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. (1975) (43)
In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. (1971) (42)
Isolation and amino acid sequence of alpha2-corticotropin-releasing factor (alpha2-CRF) from hog pituitary glands. (1962) (41)
A radioimmunoassay for γ-melanocyte stimulating hormone (1980) (41)
A re-evaluation of acetylcholine, adrenaline, nor-adrenaline and histamine as possible mediators of the pituitary adreno-corticotrophic activation by stress. (1955) (40)
Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro (1985) (40)
(Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF. (1972) (40)
The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology? (1976) (40)
Immunocytochemical localization of prosomatostatin fragments in maturing and mature secretory granules of pancreatic and gastrointestinal D cells. (1983) (39)
Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin (1983) (39)
A radioimmunoassay for γ1-melanotropin and evidence that the smallest pituitary γ-melanotropin is amidated at the COOH-terminus (1980) (38)
[Molecular structure of the hypothalamic factor (LRF) of ovine origin monitoring the secretion of pituitary gonadotropic hormone of luteinization (LH)]. (1971) (38)
In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus. (1978) (38)
Solid-phase synthesis of two glycopeptides containing the amino acid sequence 5 to 9 of somatostatin. (1981) (37)
The hypothalamic hypophysiotropic thyrotropin-releasing factor. (1971) (37)
Presence of immunoreactive β-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens☆ (1980) (35)
Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor. (1984) (35)
Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. (1974) (35)
Isolation and characterization of a γ1‐melanotropin‐like peptide from bovine neurointermediate pituitary (1981) (35)
Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron. (1978) (35)
Profound Analgesic Effects of ??-Endorphin in Man (1981) (34)
Dissociation of the acute secretions of thyrotropin and adrenocorticotropin. (1966) (34)
Growth Hormone and Diabetes in Man: Old Concepts—New Implications (1974) (32)
Isolation and characterization of caprine corticotropin-releasing factor. (1984) (32)
Primary structures of three human pancreas peptides with growth hormone-releasing activity. (1983) (32)
[Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors]. (1983) (32)
Lability of Plasma TSH Levels in the Rat in Response to Nonspecific Exteroceptive Stimuli.∗ (1966) (32)
Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors. (1984) (32)
[Somatomedin inhibition of the growth hormone secretion stimulated by the hypothalamic factor somatocrinin or the synthetic peptide hpGRF]. (1982) (31)
Synthesis of a glycotripeptide and a glycosomatostatin containing the 3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-serine residue. (1981) (30)
The effect of somatotrophic hormone on the growth of normal and hypophysectomized guinea pigs. (1954) (30)
On the method of ovarian ascorbic acid depletion as a test for luteinizing hormone (LH). (1963) (30)
Further Purification of TSH-Releasing Factor (TRF) from Sheep Hypothalamic Tissues, with Observations on the Amino Acid Composition.∗ (1965) (29)
Competition Between Thyroxine and TRF at the Pituitary Level in the Release of TSH.∗ (1967) (29)
On the mechanisms of the simultaneous release of immunoreactive beta-endorphin, ACTH, and prolactin by stress. (1980) (29)
Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease. (1981) (29)
Isolation and chemical characterization of somatostatin-28 from rat hypothalamus (1981) (29)
The hormones of the hypothalamus. (1974) (28)
Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion (1984) (28)
Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion. (1974) (27)
Beta-lipotropin and endorphins: implications of current knowledge. (1978) (27)
Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control. (1972) (27)
Physiological studies with somatocrinin, a growth hormone-releasing factor. (1985) (26)
Endogenous and exogenous vasopressin on ACTH release. (1959) (26)
Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF. (1972) (25)
Complementary DNA Sequences of Ovarian Follicular Fluid Inhibin Show Precursor Structure and Homology with Transforming Growth Factor β (1986) (25)
Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis. (1984) (25)
The brain as an endocrine organ. (1978) (25)
Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. (1981) (25)
Adrenocorticotropic Activity of Alpha Melanocyte Stimulating Hormone (α-MSH).∗ (1959) (24)
Stimulation of ovulation in the rabbit triggered by synthetic LRF. (1972) (24)
Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes (1977) (23)
beta-endorphin: cellular localization, electrophysiological and behavioral effects. (1978) (22)
Dried Staphylococcus aureus as a rapid immunological separating agent in radioimmunoassays. (1979) (22)
Somatostatin: The beginnings, 1972 (2008) (22)
The elucidation of the primary structure of the hypothalamic thyroid stimulating hormone releasing factor of ovine origin by means of mass spectrometry (1971) (22)
Control of Anterior Pituitary Hormone Secretion (1974) (22)
Stimulation of Ovulation by Purified LH-Releasing Factor (LRF) in Animals Rendered Anovulatory by Hypothalamic Lesion.∗ (1963) (21)
Profound analgesic effects of beta-endorphin in man. (1980) (20)
Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus. (1982) (20)
Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor. (1986) (20)
[Endorphins, hypothalamic and neurohypophysial peptides with morphinomimetic activity: isolation and molecular structure of alpha-endorphin]. (1976) (20)
Immunoreactive-β-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma (1979) (20)
Inhibitory effects of cysteamine on neuroendocrine function (1983) (20)
Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor. (1959) (19)
Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. (1970) (18)
Neuroendocrinology: a short historical review (2011) (17)
Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry. (1973) (17)
ON A POSSIBLE ROLE OF β-MELANOCYTE STIMULATING HORMONE (p-MSH) IN THE CENTRAL NERVOUS SYSTEM OF THE MAMMALIA:ENZYMATIC INACTIVATION IN VITRO OF β-MSH BY BRAIN TISSUE1 (1961) (17)
The regional distribution of γ 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with β-endorphin (1981) (17)
Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization (1983) (17)
Inverse effects of purified hypothalamic TRF on the acute secretion of TSH and ACTH. (1965) (17)
Isolation and Chemical Characterization of a β-CRF from Pig Posterior Pituitary Glands.∗ (1963) (17)
Somatostatin-28(1-12)-like immunoreactivity in the rat. (1982) (16)
Reversal of the inhibition of TSH secretion due to acute stress. (1967) (16)
SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER. (1964) (16)
Hypothalamic Control of Concomitant Secretion of ACTH and TSH (1967) (16)
ACTH Release by in vitro Pituitary. Effect of Pitressin and Purified Arginine-Vasopressin.∗ † (1955) (16)
Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor (1986) (16)
Isolation of α- and β-Melanocyte Stimulating Hormones (MSH) on a Preparative Scale.∗ (1960) (16)
Quantitative study of the response to LH after hypophysectomy in the ovarian ascorbic acid depletion test: effect of prolactin. (1963) (16)
Radioimmunoassays for alpha-endorphin and beta-endorphin. (1977) (15)
Release of TSH by TRF infused directly into a pituitary stalk portal vessel. (1971) (15)
Amino-terminal extension analogs of methionine-enkephalin. (1978) (15)
Hypothalamic control of the secretion of adenohypophysial hormones. (1971) (14)
Some thoughts on current research with somatostatin. (1978) (14)
Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. A historical account. (1977) (14)
Culture of enzymatically dispersed pituitary cells: functional validation of a method. (1972) (13)
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. (1972) (13)
The endocrinology of the neuron and the neural origin of endocrine cells. (1977) (13)
Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. (1976) (13)
Adrenal Sensitivity to ACTH as a Function of Time after Hypothalamic Lesion and after Hypophysectomy.∗ (1960) (12)
Stimulation of ACTH-Release in Humans by Non-Pressor Fraction from Commercial Extracts of Posterior Pituitary.∗ (1957) (12)
Effect of Perphenazine on the Secretion of Prolactin in Vivo and in Vitro 1 (1973) (12)
"en guise d'introduction ...". (2010) (12)
Concentration of Corticotropin Releasing Factor by Chromatography on Carboxymethylcellulose (1959) (12)
Concomitant release of FSH and LH induced by native and synthetic LRF. (1973) (12)
Peptides: Strategies for Antibody Production and Radioimmunoassays (1987) (11)
Control of adenohypophysial functions by peptides of the central nervous system. (1978) (11)
Hormones: A Complex Communication Network (1990) (11)
A Simple Method for Preparation of Highly Purified Vasopressin.∗ (1957) (11)
On a Method for Calculation and Analysis of Results in the McKenzie Assay for Thyrotropin (TSH).∗ (1964) (11)
Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture. (1977) (11)
Comparison of in vitro and in vivo assaying procedures for rat adenohypophysial corticotropin. (1959) (10)
PrimaryStructure oftheOvineHypothalamic Luteinizing Hormone-Releasing Factor(LRF) (1972) (9)
Chemistry and physiology of hypothalamic releasing factors for gonadotrophins. (1967) (9)
The hormones of the hypothalamus. (1974) (9)
Increase of plasma TSH concentration following injection of purified hypothalamic TRF. (1965) (9)
STEROIDOGENIC ACTIVITIES OF PURIFIED α, β, γδ,-CORTICOTROPINS AND PEPSIN DEGRADATION PRODUCTS OF β-CORTICOTROPIN1 (1960) (9)
Effect of CRF on maintenance of the adrenocorticotrophic function of anterior pituitary grafts. (1963) (9)
[Hypothalamic control of ACTH secretion as observed in results of in vitro research]. (1957) (9)
Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone. (1974) (9)
Hypothalamic control of pituitary functions : the growth hormone releasing factor (1986) (9)
An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH. (1973) (8)
Synthesis and biological activity of glycosylated analogs of somatostatin. (1979) (8)
Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content. (1969) (8)
HYPOTHALAMIC POLYPEPTIDES RELEASING PITUITARY HORMONES. (1964) (8)
A Proposal for a Reference Standard Preparation for the Hypothalamic Thyrotrophic Hormone Releasing Factor (1965) (8)
beta-Endorphin in obstetric analgesia. (1980) (8)
Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose. (1959) (8)
Negative naloxone effects in schizophrenic patients (1977) (8)
Science Over Politics (1999) (8)
Hypothalamic Hormones: Releasing and Inhibiting Factors (1973) (7)
A conversation with Roger Guillemin. Interview by Greg Lemke. (2013) (7)
Chemistry of hypothalamic releasing factors. (1973) (7)
Inhibition of DCA induced hypertension and hyalinosis by a drug acting on membrane permeability. (1951) (7)
Somatostatin: the early days. (1992) (6)
Gonadostatins and Gonadocrinin: Peptides from the Gonads Regulating the Secretion of Gonadotropins (1981) (6)
Inhibins and activins a (1988) (6)
On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide. (1972) (6)
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor. (1971) (6)
Somatostatin: the early days. (1992) (6)
Similarities and Contrasts in the Creative Processes of the Sciences and the Arts (2010) (6)
Acromegaly, Day One and Now, 120 Years Later (2006) (6)
Pioneering in Neuroendocrinology 1952–1969 (1978) (5)
Hypothalamic hypophysiotropic hormones (1976) (5)
Presence of calcium ions as a requisite for the in vitro stimulation of TSH-release by hypothalamic TRF (1967) (5)
Isolation and characterization of rat hypothalamic somatostatin-14. (1981) (5)
Elevation of plasma LH concentrations induced by LH-releasing factor as measured by radioimmunoassay in the sheep. (1969) (5)
Role of histamine in the hypothalamo-hypophyseal response to stress. (1953) (5)
Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs. (1975) (5)
[Synthetic polypeptide derivatives with TRF hypophysiotropic activity. New data]. (1969) (5)
Basic fibroblast growth factor (bFGF) enhances retinal ganglion cells’ survival and promotes axonal growth of rat transected optic nerve (1989) (5)
Evidence for the existence of two corticotrophin-releasing factors, alpha and beta. (1960) (4)
Neuroendocrine Basis of Human Disease (2004) (4)
hpGRF-44-NH2, lot no. 92-81-5G-41-47, is (human) growth hormone-releasing factor containing no trace of (ovine) corticotropin-releasing factor. (1986) (4)
[Synthetic polypeptide derivatives with thyrotropin releasing factor hypophysiotropic activity]. (1969) (4)
Physiological and clinical significance of hypothalamic and extrahypothalamic brain peptides. (1976) (4)
Myelin basic protein present in the acid extracts of rat hypothalami releases insulin and glucagon from isolated rat pancreatic islets. (1988) (4)
[The partial purification of an hypothalamic factor (LRF) stimulating the secretion of pituitary luteinizing hormone (LH)]. (1963) (4)
Genetically obese (ob/ob) mice during development. (1979) (4)
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors. (1973) (4)
Claude Bernard on Animal Heat—an Unpublished Manuscript and Some Original Notes (2015) (4)
Growth Hormone Releasing Factor: A Brief History of Its Time (1996) (3)
[Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor]. (1986) (3)
Nobel laureates' letter to President Bush. (2001) (3)
Fractionation and analysis of monkey pituitary glands for posterior lobe hormones. (1962) (3)
Goldthioglucose-Induced Hypothalamic Lesion and AGTH Release.∗ (1961) (3)
[Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine]. (1973) (3)
beta-Endorphin secretion of arginine vasopressin in vivo. (1977) (3)
Thyrotropin-Releasing Factor (TRF) of Hypothalamic Origin. A Review of Physiological and Biochemical Studies (1968) (3)
Clinical applications of hypothalamic-releasing factors. (1972) (3)
LHRH and Its Analogs (1984) (3)
Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary. (1980) (3)
Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. (1973) (3)
Hypothalamic Control of the Anterior Hypophysis and its Metabolic Implications (1959) (3)
Building Bridges through Science (2017) (3)
[Action of proteolytic enzymes on purified preparations of the TSH-hypophysiotropic hypothalamic hormone, TRF]. (1966) (3)
Highs and hopes (1989) (3)
On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin. (1962) (3)
The intestinal phase hormone (1979) (3)
Responses of the endocrine pancreas to morphine and β-endorphin (1978) (3)
Plasma beta-endorphin levels during obstetrical analgesia with synthetic beta-endorphin. (1986) (3)
Anin vivo bioassay for TSH-releasing factor (TRF) (1963) (2)
Hypothalamic-hypophysial interrelationships : a symposium, third annual scientific meeting of the Houston Neurological Society, Texas Medical Center, Houston, Texas (1956) (2)
[Biochemistry and physiology of hypothalamic hormones]. (1965) (2)
Potassium-induced stimulation of thyrotropin release in vitro. Requirement for presence of calcium and inhibition by thyroxine (1967) (2)
Stimulation of ovulation in the rabbit triggered by synthetic LRF. (1972) (2)
Hypothalamic Neurohumors in the Control of the Functions of the Anterior Hypophysis (1962) (2)
SOMATOSTATIN ANALOGS, RELATIVE IMPORTANCE OF THE DISULFIDE BRIDGE AND OF THE ALA‐GLY SIDE CHAIN FOR BIOLOGICAL ACTIVITY (1975) (2)
Inhibins and activins. Structures and radioimmunoassays. (1988) (2)
Antagonism of chlorpromazine byβ-melanocyte stimulating hormone (β-MSH) (1962) (2)
[CONCERNING THE EFFECT OF MELANOPHORETIC HORMONES ALPHA-MSH AND BETA-MSH ON THYROTROPIC AND THYROID FUNCTIONS]. (1963) (2)
Studies on corticotropin releasing factor: ion exchange chromotography of pituitary preparations. (1960) (2)
Evidence for Synergetic Dynamics in a Mammalian Pituitary Cell Perifusion System (1983) (2)
SOLID-PHASE RADIOIMMUNOASSAY OF OVINE, BOVINE, AND MURINE LUTEINIZING HORMONE. (1970) (2)
Effects of Purified Thyrotropin Releasing Factor (TRF) on Thyrotropin (TSH) Release and Pituitary Acid Phosphatase Activity (1967) (2)
[On the nature of hypothalamic substances which control the secretion of anterior pituitary hormones]. (1963) (2)
Maintenance of Normal Morphology in Adenohypophysial Transplants By Topical Administration of Hypothalamic Extracts with a Simple Method for Transplantation in a Pneumoderma Pouch.∗ (1966) (2)
Purification amino acid composition and N-terminus of the luteinizing hormone releasing factor (LRF) of ovine origin with recent studies on its biological activity. (1972) (2)
Presence of immunoreactive beta-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens. (1980) (2)
Walter B. Cannon memorial lecture. The language of polypeptides and the wisdom of the body. (1985) (2)
Neuroendocrinology: past, present and future. (2008) (1)
[Parahydroxypropiophenone (H 365); a synthetic pituitary inhibitor?]. (1951) (1)
[Adaptation to the adrenocorticotropic effect of a synthetic antihistaminic (R.P. 3277)]. (1953) (1)
[Total synthesis by solid phase of a decapeptide stimulating the secretion of LH and FSH pituitary gonadotropins]. (1971) (1)
A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus. (1980) (1)
Part 1. Plenary session ; Part 2. Pharmacological control of release of hormones including antidiabetic drugs (1962) (1)
The brain as an endocrine organ--update 1981. (1982) (1)
Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF. (1973) (1)
[Further data on the purification of the TSH-hypophysiotropic hypothalamic hormone, TRF]. (1966) (1)
Isolation and partial characterization of follistatin : A single-chain Mr 35 , 000 monomeric protein that inhibits the release of follicle-stimulating hormone ( ovary / pituitary / luteinizing hormone / gonadotropins / porcine foilicular fluid ) (1)
[Neurohumoral control of hypophysial adrenocorticotropic function]. (1960) (1)
Filtration Chromatography on Substituted Sephadex in the Purification of the Hypothalamic Hormone TRF (TSH-Releasing Factor).∗ (1965) (1)
[Study of adrenal cortex function by simultaneous measurement of corticosterone in peripheral blood and adrenal ascorbic acid]. (1957) (1)
Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor. (1979) (1)
Adrenocorticotropic activty of alpha melanocyte stimulating hormone (alpha-MSH). (1959) (1)
Hypothalamic hypophysiotrophic peptides, known and unknown. The Sir Henry Dale lecture for 1980. (1981) (1)
[High biological activity of the synthetic counterparts of hypothalamic somatostatin-28 and somatostatin-25]. (1980) (1)
Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides. (1980) (1)
CONCENTRATION OF CORTICOTROPIN RELEASING FACTOR (CRF) IN ACID EXTRACTS OF SHEEP HYPOTHALAMUS BY GEL FILTRATION AND COUNTER CURRENT DISTRIBUTION. (1963) (1)
New endocrinology of the brain. (1979) (1)
Alarm reaction and the general adaptation syndrome. (1952) (1)
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: enzymatic inactivation in vitro of beta-MSH by brain tissue. (1961) (1)
Augmentation of pentagastrin- and gastrin-stimulated acid secretion by the intestinal phase hormone. (1978) (1)
[Purification by carboxymethylcellulose chromatography of an hypothalamic factor (TRF) stimulating the secretion of thyrotropic pituitary hormone (TSH)]. (1963) (1)
Steroidogenic activities of purified alpha, beta, gamma, delta-corticotropins and pepsin degradation products of beta-corticotropin. (1960) (1)
Intrathecal Use of Beta-Endorphin as a Powerful Analgetic Agent in Man (1982) (1)
[SYMPATHETIC NEURO-OSTEO-TROPHIC SYNDROME CAUSED BY ZONA. GENERAL OBSERVATIONS ON A NEW CASE]. (1963) (1)
A Summary of In Vitro Studies on the Neuroendocrine Functions of the Hypothalamus as Related to the Adenohypophysis (1958) (1)
Active Transport of Calcium in Inverted Vesicles of Escherichia coli (2003) (1)
“Scientists versus Whaling”: Whose Errors of Judgment? (2003) (1)
[BRUCELLAR SPONDYLO-DISKITIS. GENERAL REVIEW APROPOS OF 4 OBSERVATIONS]. (1964) (0)
[Action of proteolytic enzymes on hypothalamic factors LRF and TRF stimulating the secretion of pituitary luteinizing (LH) and thyrotropic (TSH) hormones]. (1963) (0)
[Recent information on neuroendocrine chemical mediators originating in the central nervous system]. (1963) (0)
The new Pan‐American Neuroendocrine Society (2018) (0)
[Effect of Reichstein's compound L on certain effects from the administration of an anterior pituitary lobe extract]. (1953) (0)
Growth hormone releasing factor , somatocrinin , releases pituitary growth hormone in vitro ( hypothalamus / pancreas / tumor / somatostatin / perifusion (0)
[Hypertension after administration of adrenal cortex hormones and adaptation diseases]. (1953) (0)
IS PROTEIN C REALLY ACTIVATED DURING EXTRACORPOREAL CIRCULATION FOR CARDIAC SURGERY (1991) (0)
New endocrinology of the brain. (1979) (0)
[PRESENCE IN A SALINE EXTRACT OF HYPOTHALAMUS OF AN RSH TYPE FOLLICLE-STIMULATING ACTIVITY]. (1963) (0)
Regional dissociation of f ,-endorphin and enkephalin contents in rat brain and pituitary ( opiates / radioimmunoassay / neurotransmitter / adrenalectomy and hypophysectomy / myelin basic protein ) (0)
[Does the melanophoretic hormone beta-MSH play a role in the functions of the central nervous system in the higher mammals?]. (1960) (0)
Purification of gonadostatin from bovine seminal plasma (BSP). (1982) (0)
[Nephrosclerotic and prophlogistic effect of various preparations of somatotropic hormones]. (1952) (0)
[Adrenal cortical response to hypophysial corticotropin hormone in the rat, as a function of sex. In vivo study]. (1961) (0)
News in brief (2007) (0)
Production of arterial hypertension by cortisone in the absence of sodium. (1953) (0)
[Electrotherapy in circulatory disorders of the legs]. (1977) (0)
The potential use of LRF and its analogues for regulating fertility. (1981) (0)
Salt and the scholar (1983) (0)
Invited commentary (1979) (0)
Basic research and the practice of medicine. (2006) (0)
Evolution of autochthonous agriculture in the savannahs of Ubangi-Shari (1956) (0)
[Hypothalamic factor in the secretion of ACTH; in vivo activity in animals with hypothalamic lesions or pharmacological block]. (1958) (0)
Claude Bernard on Experimental Medicine—Some Unpublished Notes (2015) (0)
[Chymotrypsin in rheumatology. propos of372 cases]. (1969) (0)
A Conversation with (2013) (0)
成長ホルモン放出因子(ソマトクリニン)を産生する視床下部ノイロンの解剖学的研究 (1986) (0)
[The corticotherapeutic escalade]. (1965) (0)
Subject Index, Vol. 54, Supplement 1, 1993 (1993) (0)
[Roles of cyclic AMP and calcium in the mechanism of the release of growth hormone by somatocrinin]. (1984) (0)
On thein vitro bioassay for measuring melanophoretic activity (1961) (0)
Color Plates (2010) (0)
[Inhibiting action of phenergan (3277 R. P.) on the experimental hypertension syndrome produced by desoxycorticosterone acetate]. (1951) (0)
[POTENTIATION OF THE BIOLOGICAL ACTION OF THE LRF HYPOTHALAMIC FACTOR OF BOVINE OR OVINE ORIGIN BY SYNTHETIC ARGININE-VASOPRESSIN]. (1964) (0)
Contents, Vol. 2, 1967 (1967) (0)
[Hypertension and hyalinosis due to methyl-androstenediol]. (1953) (0)
[Action of mineral-corticoids on the behavior of the kidney towards vasopresor substances of angiotonin type]. (1950) (0)
Targeted lesion of caudal brainstem catecholamine neurons reveals their role in symptoms of fatigue (2011) (0)
PrimaryStructure ofSomatostatin, A Hypothalamic Peptide ThatInhibits theSecretion ofPituitary GrowthHormone (somatotropin release/Edman degradation/dansylation/mass spectrometry) (1973) (0)
B-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins ( lipotropin / morphine / brain / endogenous ligand / pituitary ) (0)
Quantitative aspects of percolation for the extraction of oxytocin and vasopressin. (1962) (0)
Inhibin and its cleaning. (1986) (0)
Floyd Bloom: the next editor-in-chief of Science (1995) (0)
[Gonadostatin and gonadocrinin, polypeptides of ovarian origin with hypophysiotropic activity]. (1979) (0)
[Reflex algoneurodystrophies and high-frequency pulsations]. (1977) (0)
Subject Index Vol. 36, 1983 (1983) (0)
[Apropos of a case of myeloid splenomegaly with acute blastic transformation]. (1963) (0)
[PURIFICATION OF THE HYPOTHALAMIC FACTOR (TRF) STIMULATING THE SECRETION OF THE THYROTROPIC PITUITARY HORMONE (TSH) BY THE COUNTER-CURRENT DISTRIBUTION METHOD]. (1964) (0)
[Trial use of aescine by drug dielectrolysis--apropos of 80 cases]. (1977) (0)
[Electrotherapy in inflammatory osteo-articular reactions]. (1977) (0)
[The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]. (1975) (0)
Process for producing a peptide having an impact on human and other mammalian hypofysekirtelfunktion (1983) (0)
Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma. (1979) (0)
"en guise d'introduction ...". (2010) (0)
Antagonism of chlorpromazine by beta-melanocyte stimulating hormone (beta-MSH). (1962) (0)
[Mineral-corticoid inhibition of renal inactivation of vasopressive substances]. (1950) (0)
Significance of somatostatin, newcomer from the hypothalamus. (1975) (0)
Neuropeptides of the gut: a newly discovered major control system. Invited commentary. (1979) (0)
Solubility of the hypothalamic hormones TSH-releasing factor (TRF) and LH-releasing factor (LRF) in organic and alcoholic solvents (1967) (0)
Biological Activity and Mechanisms of Action of Somatocrinin, Growth Hormone Releasing Factor, on the Release of Growth Hormone in Vitro and its Antagonism by Somatostatin (1984) (0)
Contents, Vol. 2, 1971/72 (1971) (0)
[Acute porphyria with neurological manifestations in the course of 3 generations. Clinical and biological findings]. (1962) (0)
[Persistence of the biological activity of the luteinizing hormone after heating to 100 degrees C in an acid medium]. (1962) (0)
Follistatin and method thereof for cleaning. (1988) (0)
[Hormonal pathogenesis of experimental cardiovascular lesions; cardiovascular lesions of adaptation diseases]. (1952) (0)
Analogifremgangsmaade for the preparation of pGRF pGRF analogs or peptides, pharmaceutically acceptable addition salts thereof as well as intermediate for use in the method (1983) (0)
Neural modulation of immunity : proceedings of an international symposium held under the auspices of the Princess Liliane Cardiology Foundation in Brussels, Belgium, October 27 and 28, 1983 (1985) (0)
[Study of the histaminergic mechanism of the stimulation of the pituitary-adrenal axis by stress]. (1953) (0)
SYNTHETIC LUTEINIZING HORMONE RELEASING FACTOR ANALOGS, SERIES OF SHORT-CHAIN AMIDE LRF HOMOLOGS CONVERGING TO THE AMINO TERMINUS (1973) (0)
[Peptides of cerebral origin. Their growing importance in physiology and medicine]. (1978) (0)
[Routine use of a large electronic computer in the mathematical analysis of results in experimental biology]. (1962) (0)
[On the existence of 2 types of substances with hypophysiotropic activity: a-CRF and beta-CRF (corticotrophin-releasing factor)]. (1960) (0)
The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin. (1981) (0)
[Thyroid function in the nephrotic syndrome]. (1984) (0)
[Not Available]. (1953) (0)
Pioneering in the Isolation of Biologically Active Peptides and a Look to the Future (1981) (0)
A radioimmunoassay for gamma-melanocyte stimulating hormone. (1980) (0)
On the action ofβ-melanocyte stimulating hormone (β-MSH) on spontaneous electric discharge of the transparent knife fish,G. eigenmannia (1962) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roger C. L. Guillemin?

Roger C. L. Guillemin is affiliated with the following schools:

Baylor University

Roger C. L. Guillemin's Academic­Influence.com Rankings

Why Is Roger C. L. Guillemin Influential?

Roger C. L. Guillemin's Published Works

Published Works

What Schools Are Affiliated With Roger C. L. Guillemin?

Roger C. L. Guillemin's AcademicInfluence.com Rankings